Latest Venous thrombosis Stories
The Firm is representing individuals in Xarelto lawsuits that allege use of the blood-thinning medication caused serious complications, including uncontrollable internal bleeding. New
The Firm is evaluating Xarelto lawsuits on behalf of patients who experienced uncontrollable internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other complications allegedly
- Poster on research about investigational, specific antidote for PRADAXA also to be presented RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Xarelto Page Launched to Monitor Lawsuits Being Filed on Behalf of Patients Who Allege the Blood Thinner Causes Severe Internal Bleeding and Uncontrollable Bleeding New
- Committee votes 9 to 1 to recommend approval of once-daily SAVAYSA for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF) TOKYO,
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable internal bleeding, blood clots, and other serious complications, allegedly due to their use of the
The portable VenaPro system helps prevent post-operative Deep Vein Thrombosis Irving, Texas (PRWEB) October 21, 2014 The leading podiatry specialists
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable bleeding and other serious complications, allegedly due to their use of the blood thinner.
The National Blood Clot Alliance will continue its long-standing collaboration with the Centers for Disease Control and Prevention (CDC), as it has been awarded another five-year CDC Cooperative Agreement
The Firm is evaluating potential legal claims on behalf of individuals who allegedly suffered uncontrollable internal bleeding and other serious side effects due to the use of the blood thinning
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.